HLS Therapeutics Annual Revenue, Number of Employees, Growth and Funding

Claim your profile

Overview

Location:
Toronto, ON Canada
Total Funding:N/A
Industry:Pharma
Founded:2015
Lead Investor(s):N/A
Press
Claim your profile

City Ranking

State Ranking

Growjo 10k Ranking

Estimated Revenue & Financials

  • HLS Therapeutics's estimated annual revenue is currently $14.9M per year.
  • HLS Therapeutics received $125.0M in venture funding in September 2018.
  • HLS Therapeutics's estimated revenue per employee is $201,000

Employee Data

  • HLS Therapeutics has 74 Employees.
  • HLS Therapeutics grew their employee count by 85% last year.
  • HLS Therapeutics currently has 1 job openings.

Executive Contacts

NameTitle
Alec WilsonBrand Manager Clozaril
Hemanth VargheseHead Of Corporate Strategy & Business Development
Elizabeth FryManager, Therapeutic Area Development
Ryan LennoxGeneral Counsel
David IwanickiDirector Of National Accounts And Rsap Program
Greg GubitzChief Executive Officer
Gilbert GodinPresident and Chief Operating Officer
Tim HendricksonChief Financial Officer
Hemanth VargheseHead of Corporate Strategy and Business Development
sanjiv SharmaChief Commercial Officer

The Heritage of Life Sciences Products HLS Therapeutics is about maintaining the heritage of life science products. We are dedicated to keeping trusted branded drugs on the market. HLS provides access to medications critical to Health Care Providers, patients and their caregivers with the high-quality brand names they trust. Who We Are HLS Therapeutics Inc. is a specialty pharmaceutical company dedicating itself to acquiring and distributing commercial stage mature, or legacy, branded pharmaceutical drugs for the North American markets. Our management team is comprised of seasoned pharmaceutical executives with a strong track record of success. Building on the expertise of our founders, HLS is focused on treatment products for the central nervous system, soon to be followed by specialty products in other therapeutic areas. HLS Therapeutics focuses on the North American market and has operational locations in Toronto (Etobicoke, Ontario), and Philadelphia (Rosemont, Pennsylvania), We source our products from the drug's originator or from best-in-class manufacturing partners, ensuring our brands are manufactured with the highest standards of quality and in compliance with FDA and Health Canada's regulations. Our Goal/Our Mission HLS is dedicated to the stewardship of branded pharmaceuticals through their life cycle during and post exclusivity, providing access to treatments critical to Health Care Providers, patients and their caregivers with the brand names they trust.

keywords:N/A

74

Number of Employees

$14.9M

Revenue (est)

1

Current Jobs

85%

Employee Growth %

N/A

Total Funding

N/A

Valuation

N/A

Accelerator

N/A

Type

NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
Turnkey Modular...
$7.4M3728%N/A
PharmEng Techno...
$33.8M16813%N/A
Allphase Clinic...
$8M4014%N/A
Janssen
$1541.1M76677%N/A
Fresenius Kabi ...
$23.3M11622%N/A
Everest Clinica...
$35.2M17517%N/A
Robarts Clinica...
$51.7M25714%N/A
Novapharm Limit...
$20.1M1003%N/A
Dalton Pharma S...
$26.9M1345%N/A
Acerus Pharma
$7M353%N/A

HLS Therapeutics News

09/03/2019 - Update: HLS Therapeutics (TSE:HLS) Stock Gained 79% In The Last Year

HLS Therapeutics Inc. (TSE:HLS) shareholders might be concerned after seeing the share price drop 18% in the last month. But looking back ...

09/08/2019 - Should HLS Therapeutics Inc. (TSE:HLS) Be Part Of Your Income Portfolio?

HLS Therapeutics has only been paying a dividend for a year or so, so investors might be curious about its 1.4% yield.” Before you buy any ...

09/03/2019 - Trading Watch: Reviewing the Numbers for HLS Therapeutics Inc. (TSX:HLS)

HLS Therapeutics Inc. (TSX:HLS) has a current EV or Enterprise Value of 457566. The EV displays how the market assigns value to a firm as a ...

HLS Therapeutics Funding

DateAmountRoundLead InvestorsReference
2018-09-13$125.0MUndisclosedSilicon Valley BankArticle